Zobrazeno 1 - 10
of 108
pro vyhledávání: '"E. W. Seely"'
Publikováno v:
Journal of endocrinological investigation. 35(8)
Exogenous estrogens have been shown to affect markers of cardiovascular risk in women.The objective of this study was to determine the effect of menstrual cycle phase on markers of cardiovascular risk in young, healthy women with regular menstrual cy
Autor:
E. W. Seely
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 74:1436-1440
Autor:
E. W. Seely
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 74:150-156
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(11)
Estrogen is known to increase serum T4-binding globulin (TBG) concentrations, thereby increasing serum total T4 concentrations. Serum free T4 concentrations, however, remain normal. Tamoxifen, a selective estrogen receptor modifier (SERM), also raise
Autor:
S. R. Hoyer, Judith G. Regensteiner, A. M. Jacobsen, P. Casanova, B. Clarke, K. B. Czech, P. O'Hara, M. Kocal, Pamela G. Watson, B. N. Calonge, M. L. Jeffirs, K. A. Smith, K. M. Callaghan, B. M. Kennedy, P. V. Nash, B. Van-Dorsten, J. Mendez, M. Quitingon, A. A. Hebert, H. Seagle, T. Franklin, F. G. Guillory, Donna H. Ryan, M. M. Rozek, K. A. Stepp, B. Harding-Clay, B. J. Goldstein, D. Williamson, J. J. Zachwieja, P. C. Vicknair, David A. Ehrmann, F. L. Greenway, J. Perault, Ronald B. Goldberg, M. Nicosia, P. Rowe, C. M. Mobley, L. E. Melancon, R. M. Hilbrich, R. T. Tulley, W. L. McNabb, M. A. Malloy, D. A. Collins, J. A. Tobian, L. M. Kula, J. T. Mendoza, H. J. Florez, Margaret J. Matulik, J. A. St. Amant, J. Ojito, S. C. Steinke, D. Schweizer, S. Rubtchinsky, A. R. Semenske, C. DeSandre, R. Liberoni, J. Pan, C. M. Champagne, R. P. Donahue, E. Caballero, George A. Bray, K. G. Smith, H. Miettinen, J. P. Burke, E. Tucker, Steven M. Haffner, M. Miller-Stone, James O. Hill, John Spandorfer, L. Testaverde, E. W. Seely, K. E. Lawton, Edward S. Horton, V. McLymont, O. P. Ganda, R. A. Arky, L. Dawson, B. T. Jortberg, I. W. Culbert, L. Murphy, L. A. Mykkanen, B. Eberhardt, J. Calles, A. Giannella, G. Geiger, C. Lark, M. Bryant, K. S. Polonsky, R. Prineas, L. H. Morris, D. A. Sanford, Jennifer C. Lovejoy, S. D. Jackson, Richard F. Hamman, L. L. Smith, C. Pepe, C. F. Oldmixon, Maria G. Montez
Publikováno v:
Diabetes care. 23(11)
OBJECTIVE: The Diabetes Prevention Program (DPP) is a 27-center randomized clinical trial designed to evaluate the safety and efficacy of interventions that may delay or prevent development of diabetes in people at increased risk for type 2 diabetes.
Publikováno v:
The Journal of reproductive medicine. 41(4)
Primary hyperaldosteronism is an uncommon disorder, and there are few reports of its occurrence and management in pregnancy.Primary hyperaldosteronism was suspected before pregnancy in a 31-year-old women with refractory hypertension and hypokalemia.
Autor:
E W, Seely, S W, Graves
Publikováno v:
Comprehensive therapy. 19(3)
Publikováno v:
Journal of the Endocrine Society; 2024 Supplement, Vol. 8, pA1-A1192, 3359p
Autor:
Miranda, Constanza1 constanzamiranda@jhu.edu, McClam, Rachel1
Publikováno v:
Proceedings of the ASEE Annual Conference & Exposition. 2023, p1-10. 10p.
Autor:
Bangsbo, Jens
Publikováno v:
European Journal of Sport Science; Aug2024, Vol. 24 Issue 8, p1162-1175, 14p